Skip to main content
. 2024 Oct 10;27(11):111117. doi: 10.1016/j.isci.2024.111117

Figure 2.

Figure 2

Estimated number of SARS-CoV-2 infections averted

(A) This panel shows the estimated number of SARS-CoV-2 infections averted among participants of the REDUCE study.

(B) This panel shows the estimated number of SARS-CoV-2 infections averted in the district of Schwaz. The counterfactual scenario assumes that numbers of SARS-CoV-2 infections would have been the same as in other districts of Tyrol. aPeriod in which BNT162b2 dose 2 (April 8-13, 2021) and dose 3 (November 20-28, 2021) were administered within the REDUCE study. Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus type 2.